Inflammatory biomarkers and psychological variables to assess quality of life in patients with inflammatory bowel disease: a cross-sectional study
Impacto
Scholar |
Otros documentos de la autoría: González-Moreta, Rafael; Cebolla Marti, Ausias; Almodóvar, Isabel; Navarrete Hidalgo, Jaime; García Esparza, Mª Angeles; Soria, Jose; Lisón Párraga, Juan Francisco
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36084
comunitat-uji-handle3:10234/36085
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
Inflammatory biomarkers and psychological variables to assess quality of life in patients with inflammatory bowel disease: a cross-sectional studyAutoría
Fecha de publicación
2024Editor
Taylor and FrancisISSN
0785-3890; 1365-2060Cita bibliográfica
González-Moret, R., Cebolla-Martí, A., Almodóvar-Fernández, I., Navarrete, J., García-Esparza, Á., Soria, J. M., & Lisón, J. F. (2024). Inflammatory biomarkers and psychological variables to assess quality of life in patients with inflammatory bowel disease: a cross-sectional study. Annals of Medicine, 56(1). https://doi.org/10.1080/07853890.2024.2357738Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
https://www.tandfonline.com/doi/full/10.1080/07853890.2024.2357738Versión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Background:
Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition. While inflammatory biomarkers are valuable for diagnosing and monitoring the disease, their correlation with patients’ quality ... [+]
Background:
Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition. While inflammatory biomarkers are valuable for diagnosing and monitoring the disease, their correlation with patients’ quality of life (QoL) is not well-established.
Purpose:
This study aims to investigate the correlations between inflammatory biomarkers and the quality of life (QoL) variables of individuals diagnosed with IBD in clinical remission.
Methods:
The sample of this cross-sectional study included 74 patients (80% women; 45 ± 11 years old) diagnosed with IBD. Outcome variables included faecal calprotectin (FC), C-reactive protein (CRP), cortisol levels from hair samples, and anxiety and depression assessed using the Hospital Anxiety and Depression Scale (HADS-A and HADS-D, respectively), alongside QoL evaluated with the Inflammatory Bowel Disease Questionnaire 32 (IBDQ-32). Bivariate correlations were calculated using the Pearson correlation coefficient, and stepwise linear regression analyses were conducted to identify independent factors contributing to IBDQ-32 scores.
Results:
The IBDQ-32 did not significantly correlate with any biomarkers. However, it exhibited a large and statistically significant negative correlation with HADS-A (r = −0.651) and HADS-D (r = −0.611) scores (p < 0.001). Stepwise linear regression analyses indicated that HADS-A was a significant and independent predictor for IBDQ-32 scores (Adjusted R2 = 0.41, β = −0.65, p < 0.001).
Conclusions:
Inflammatory markers such as CRP, FC, or cortisol in hair do not play a decisive role in assessing the QoL of IBD patients. These findings emphasize the significance of considering psychological factors in evaluating and managing QoL in IBD patients in order to identify severity, suggesting that instruments like HADS should be integral to comprehensive patient assessments. [-]
Publicado en
Annals of Medicine, 2024, vol. 56Entidad financiadora
Cardenal Herrera CEU University Elche | CIBER of Epidemiology and Public Health | CIBER of Physiopathology of Obesity and Nutrition
Código del proyecto o subvención
CEU-UCH 2023-2024 | INDI23/62 | GIR2313 | INDI23/20 | CIBERESP CB22/02/00052 | CIBEROBN CB06/03/0052
Derechos de acceso
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- INF_Articles [281]
Excepto si se señala otra cosa, la licencia del ítem se describe como: © 2024 The Author(s). Published by informa UK limited, trading as Taylor & francis Group. This is an open Access article distributed under the terms of the creative commons Attribution-noncommercial license (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.